AnaptysBio to Drop Eczema Drug Candidate
AnaptysBio to Drop Eczema Drug Candidate After Trials Miss Endpoints; Shares Fall
AnaptysBio shares plummeted in premarket trading Wednesday after the company said it will discontinue its dermatitis treatment after the drug failed to meet its targets in recent trials. Shares fell over 39% to $14 ahead of the morning bell.
Nara Smith shared images and a lengthy caption detailing the health challenges she's experienced in the three years since her ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
Nara Smith shared pictures of her recent eczema flare-ups on Instagram, where the model got candid about her journey with the ...
Brave Rebecca Ebbage, 31, began breaking out in painful weeping sores when she suddenly stopped using the steroid cream she ...
It's still early science -- studies in mice and in human cells -- but researchers are on the trail of an effective new ...
Discover how different types of weather, from scorching heat to chilly winds, can wreak havoc on your skin and learn ...
These ten essentials keep my skin hydrated, soothed, and protected from inflammation, itchiness, and occasional scaliness.
Chronic exposure to irritants, allergens, and repetitive hand washing are established risk factors for chronic hand eczema.
Eczema-prone skin needn't mean a mundane moisturiser; our edit includes the ingredient-led, the fragranced and the luxurious ...
Managing eczema or psoriasis requires a wide approach Hence by focusing on sugar control a high-protein diet and incorporating diluted apple cider vinegar you can take meaningful steps toward healthie ...
Q32 Bio delivered a "messy" update for its eczema and alopecia treatment, leading the biotech stock to collapse to a record ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback